Browse hierarchy: [Gastroenterology, Urology (GU)](/submissions/GU) → [Subpart B — Diagnostic Devices](/submissions/GU/subpart-b%E2%80%94diagnostic-devices) → [21 CFR 876.1530](/submissions/GU/subpart-b%E2%80%94diagnostic-devices/876.1530) → QTH — Endoscopic Light-Projecting Measuring Device

# QTH · Endoscopic Light-Projecting Measuring Device

_Gastroenterology, Urology · 21 CFR 876.1530 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/GU/subpart-b%E2%80%94diagnostic-devices/QTH

## Overview

- **Product Code:** QTH
- **Device Name:** Endoscopic Light-Projecting Measuring Device
- **Regulation:** [21 CFR 876.1530](/submissions/GU/subpart-b%E2%80%94diagnostic-devices/876.1530)
- **Device Class:** 2
- **Review Panel:** [Gastroenterology, Urology](/submissions/GU)

## Identification

An endoscopic light-projecting measuring device is an accessory used in conjunction with an endoscope to project light on a mucosal surface and use software to determine the dimensions of observable anatomy and pathology in the gastrointestinal tract. The device provides no therapeutic or diagnostic function.

## Classification Rationale

Class II (special controls). The device is classified as Class II because it is not a device for which general controls alone are sufficient to provide reasonable assurance of the safety and effectiveness of the device, and there is sufficient information to establish special controls to provide such assurance.

## Special Controls

In combination with the general controls of the FD&C Act, the endoscopic light-projecting measuring device is subject to the following special controls:

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [DEN210032](https://fda.innolitics.com/submissions/GU/subpart-b%E2%80%94diagnostic-devices/QTH/DEN210032.md) | AccuMeasure System | RQMIS, Inc. | Jul 26, 2022 | DENG |

## Top Applicants

- RQMIS, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/GU/subpart-b%E2%80%94diagnostic-devices/QTH](https://fda.innolitics.com/submissions/GU/subpart-b%E2%80%94diagnostic-devices/QTH)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com
